Profile: IPCA Laboratories Ltd (IPCA.BO)
IPCA.BO on Bombay Stock Exchange
Price Change (% chg)
IPCA Laboratories Limited is a pharmaceutical company. The Company is a manufacturer of active pharmaceutical ingredients (APIs)-Atenolol (anti-hypertensive), Chloroquine Phosphate (anti-malarial), Furosemide (diuretic), Hydroxychloroquine Sulphate (NSAID), Metoprolol Succinate (anti-hypertensive), Metoprolol Tartrate (anti-hypertensive) and Pyrantel Salts (anthelmintic). Its formulations basket includes generics for the developed markets and branded formulations for emerging markets. The Company manufactures over 350 formulations in virtually every dosage form: oral solids and liquids, dry powders for suspension, and injectables (liquid and dry). The Company’s subsidiaries include Ipca Pharmaceuticals, Inc., Ipca Laboratories (U.K.) Ltd., Ipca Pharma Nigeria Ltd., National Druggist (PTY) Ltd and Ipca Pharma (Australia) Pty Ltd.
IPCA Laboratories Ltd
142 AB, Kandivli Industrial Esta